Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile

Background: Previous studies have assessed the role of Type 1 diabetes (DM1) antibodies as predictors of the natural history of disease. Aim: To determine the frequency and combinations of positivity for DM1 antibodies in patients with DM1 and the relationship between antibody positivity and the a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vera,Francisco, Jofré,Paulina, Rodríguez,David, Lagos,Rodrigo, Quiroga,Teresita, Grassi,Bruno, Pollak,Felipe
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2021
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000300330
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872021000300330
record_format dspace
spelling oai:scielo:S0034-988720210003003302021-10-14Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de ChileVera,FranciscoJofré,PaulinaRodríguez,DavidLagos,RodrigoQuiroga,TeresitaGrassi,BrunoPollak,Felipe Antibodies Diabetic Ketoacidosis Diabetes Mellitus, Type 1 Insulin Antibodies Immunoassay Background: Previous studies have assessed the role of Type 1 diabetes (DM1) antibodies as predictors of the natural history of disease. Aim: To determine the frequency and combinations of positivity for DM1 antibodies in patients with DM1 and the relationship between antibody positivity and the age of the patient. To explore the relationship between history of insulin therapy or diabetic ketoacidosis (DKA) at the onset of the disease with antibody positivity in a subsample. Material and Methods: Data was gathered from every sample processed for DM1 antibodies in our laboratory between January 2015 and September 2019. Medical records from 84 patients who tested positive for at least one antibody were revised to study the relationship between insulin therapy or DKA at the onset of the disease with antibody positivity. Results: Forty percent of DM1 antibody tests were positive. Among positive tests, 1, 2, 3 or 4 DM1 antibodies were detected in 48%, 33%, 17% and 3% of cases, respectively. The likelihood of testing positive was inversely related with age for ICA, GAD, IA-2, ZnT8 and directlyproportionalforIAA (p= &#8722;0,012; &#8722;0,013; &#8722;0,014; &#8722;0,009; 0,005 respectively). An association between DKA at the onset of the disease and IA-2 positivity was observed (Odds ratio (OR) 5.38 95% confidence intervals (CI) 1.79 &#8722; 16.16, P < 0.01). No association was found between IAA positivity and history of insulin therapy (OR 2.25 95%CI 0.63 &#8722; 7.90, P = 0.2403). The results obtained from this study represent a novel local profile of DM1 antibody data, highlighting a relationship between antibody positivity and age.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.3 20212021-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000300330es10.4067/s0034-98872021000300330
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Antibodies
Diabetic Ketoacidosis
Diabetes Mellitus, Type 1
Insulin Antibodies
Immunoassay
spellingShingle Antibodies
Diabetic Ketoacidosis
Diabetes Mellitus, Type 1
Insulin Antibodies
Immunoassay
Vera,Francisco
Jofré,Paulina
Rodríguez,David
Lagos,Rodrigo
Quiroga,Teresita
Grassi,Bruno
Pollak,Felipe
Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
description Background: Previous studies have assessed the role of Type 1 diabetes (DM1) antibodies as predictors of the natural history of disease. Aim: To determine the frequency and combinations of positivity for DM1 antibodies in patients with DM1 and the relationship between antibody positivity and the age of the patient. To explore the relationship between history of insulin therapy or diabetic ketoacidosis (DKA) at the onset of the disease with antibody positivity in a subsample. Material and Methods: Data was gathered from every sample processed for DM1 antibodies in our laboratory between January 2015 and September 2019. Medical records from 84 patients who tested positive for at least one antibody were revised to study the relationship between insulin therapy or DKA at the onset of the disease with antibody positivity. Results: Forty percent of DM1 antibody tests were positive. Among positive tests, 1, 2, 3 or 4 DM1 antibodies were detected in 48%, 33%, 17% and 3% of cases, respectively. The likelihood of testing positive was inversely related with age for ICA, GAD, IA-2, ZnT8 and directlyproportionalforIAA (p= &#8722;0,012; &#8722;0,013; &#8722;0,014; &#8722;0,009; 0,005 respectively). An association between DKA at the onset of the disease and IA-2 positivity was observed (Odds ratio (OR) 5.38 95% confidence intervals (CI) 1.79 &#8722; 16.16, P < 0.01). No association was found between IAA positivity and history of insulin therapy (OR 2.25 95%CI 0.63 &#8722; 7.90, P = 0.2403). The results obtained from this study represent a novel local profile of DM1 antibody data, highlighting a relationship between antibody positivity and age.
author Vera,Francisco
Jofré,Paulina
Rodríguez,David
Lagos,Rodrigo
Quiroga,Teresita
Grassi,Bruno
Pollak,Felipe
author_facet Vera,Francisco
Jofré,Paulina
Rodríguez,David
Lagos,Rodrigo
Quiroga,Teresita
Grassi,Bruno
Pollak,Felipe
author_sort Vera,Francisco
title Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
title_short Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
title_full Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
title_fullStr Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
title_full_unstemmed Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile
title_sort marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de chile
publisher Sociedad Médica de Santiago
publishDate 2021
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000300330
work_keys_str_mv AT verafrancisco marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT jofrepaulina marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT rodriguezdavid marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT lagosrodrigo marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT quirogateresita marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT grassibruno marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
AT pollakfelipe marcadoresinmunologicosdediabetestipo1analisisde4164perfilesenuncentrodesaluddechile
_version_ 1718437189450203136